In this weeks roundup we will discuss a familyman’s battle against crony medicine “Chicago-based Errant Gene Therapeutics has sued Third Rock Ventures and Bluebird Bio CEO Nick Leschly, alleging that the pair conspired to ‘kill’ a competing medical treatment.”
We also go over a study about people aging with HIV, a clincial trial regarding liver cancer, and Hidradenitis Suppurativa patients are at greater risk for having NAFLD.
A concerning trial that involved premature infants and Nestle. The FDA making changes to the IRB, and two powerhouse pharma companies teamed up to start food allergy trials, and a lot more!
Make sure to tune in on Aug 14th we will be talking to XBiotech about their HS drug pipeline.